Answer: LBBAP prevents maladaptive remodeling by maintaining normal calcium handling proteins (SERCA2a, phospholamban), reducing oxidative stress markers, and preserving mitochondrial function. It avoids the abnormal gene expression patterns (fetal gene program reactivation) seen with dyssynchronous RV pacing.
Answer: LBBAP maintains optimal ventricular strain patterns and reduces mechanical dispersion, leading to improved cardiac efficiency. Studies show 15-20% better mechanical efficiency compared to RV pacing, with reduced oxygen consumption and improved ventriculo-arterial coupling.
Answer: Recent innovations include: steerable delivery systems, leads with enhanced fixation mechanisms, integrated mapping capabilities, and leads designed specifically for septal anatomy. Future developments focus on leadless LBBAP systems and multi-electrode arrays.
Answer: LBBAP preserves normal autonomic modulation by maintaining physiological ventricular activation sequences. This results in better heart rate variability, improved baroreflex sensitivity, and more favorable sympathovagal balance compared to conventional pacing.
Answer: Computational models simulate electrical propagation from LBBAP sites, helping optimize lead placement, predict QRS morphology, and understand activation patterns. Patient-specific models incorporating cardiac anatomy and fibrosis distribution are emerging for personalized LBBAP planning.